60 plus internationally established speakers. Attend 1, 2, or 3 days.
22 credit points CPE/CME (3 days), 6 credit points CPE/CME (3 days), 6
credit points/day attendance.
Contact Complete Congress Services Tel: +44 (0) 1625 624091 Fax: +44 (0)
1625 624075 E-mail:
[log in to unmask] or Dr David Allen, Tel +44 (0) 161 275
7705 E-mail: [log in to unmask]
VACCINES AND IMMUNISATION INTO THE NEXT MILLENNIUM
6-9 September 1999. Manchester, United Kingdom
THE UNIVERSITY OF MANCHESTER,
CO-CHAIRMEN:
Professor C de Quadros, Director, Special Program for Vaccine and
Immunisation, PAHO, USA
Professor M Levine Director, Center for Vaccine Development, Maryland
University, USA
Dr. B Melgaard, Director, Global Programme for Vaccines and
Immunisation, WHO, Switzerland
Dr. W Orenstein, Director, National Immunisation Program, CDC, USA
Dr. David Salisbury, Principal Medical Officer (Immunisation),
Department of Health, UK
CONFERENCE ORGANISERS:
Scientific Director/Conference Organiser: Dr. D Baxter, Conference
Administrator: Dr. David Allen of Manchester University Medical School,
Department of Public Health and Health Promotion, School of Epidemiology
and Health Sciences, UK
SPEAKERS INCLUDE:
Mr. James Badenoch QC, Dr. Steven Black, Dr. Robert Booy, Dr. Anthony FT
Brown, Professor Keith Cartwright, Dr. Robert T. Chen, Dr. L Coudeville,
Dr. James E. Crowe, Jr., Professor Stanley S Davis, Dr. Duclos, Dr.
David Elliman, Professor Juhani Eskola, Dr Ian Feavers, Dr. David S.
Fedson, M.D., Dr. Figueroa, Dr. Adam Finn, Dr. Bruce G. Gellin, MD, Dr.
Anne Gershon, Dr. Brigitte Gicquel, Dr. Anne Ginsberg, Dr. Roger I
Glass, Dr. Gregory M. Glenn, Dr. David Goldblatt, Celia Hall, Karen
Howell, Dra. Concepcion Campa Huergo, Mr. Adrian J. Ivinson, Dr.
Margaret I. Johnston Ph.D., Dr. E Kaczmarski, Ms. Ann Kempe, Professor
Paul Henri Lambert, Professor Vincent H.L. Lee, Dr. S Lockart, Dr.
Jeannette Martin, Dr. François Meurice, Dr. Mark Miller, Dr. E Miller,
Dr. Karl Nicholson, Dr. Patrick Olin, Professor John Oxford, Prof Heikki
Peltola, Dr. Joan Sawyer, Dr. Henry Shinefield, Dr. Claire-Anne
Siegrist, Dr. Claire- Anne Siegrist, Dr. Lone Simonsen, Dr. Peter Stern,
Dr Roy Widdus, Dr. J Yarwood.
TOPICS WILL HAVE A WORLDWIDE PERSPECTIVE AND INCLUDE:
Neisseria meningitidis - Conjugate Vaccines & the role of the A and C
vaccine. Measles Control by Vaccination: Adverse Events. Chicken Pox
Vaccine: Use amongst children and adults. Pneumococcal disease and
control by vaccination; New Conjugate Vaccines. Influenza Control and
Vaccination. Whopping Cough - Whole Cell and Sub-unit Vaccines.
Medical Negligence - Preparing a Case. Addressing antivaccine issues.
Vaccination and the Media. Informed Consent. RSV vaccines. Mucosal
delivery via the nasal route. Lessons from smallpox, polio and measles
about disease control by vaccination. Vaccination and the Internet.
Immunology and Molecular Biology Update - The application of molecular
genetics to vaccine development. Vaccinating immunocompromised
individuals. Public perceptions of vaccines or building/restoring the
public's trust in
immunisation. New TB vaccines, Rotavirus vaccines. An overview of HIV
vaccines development, Improving vaccine uptake. New technologies
applied to vaccine development. Organising vaccine trials. Preparing a
protocol. Preventing Gastro-intestinal disease in travellers abroad.
Health Service reforms and their impact on vaccine uptake. Lyme
Vaccine. Infant vaccine responses. Anaphylaxis management.
For further information, please contact: James Arthur, Complete Congress
Services, 19 King Edward Street, Macclesfield, Cheshire, SK10 1AQ UK
Tel: +44 (0) 1625 624060 Fax +44 (0) 1625 430544
Email: [log in to unmask]
If you would like to apply to attend the Conference you can also fill
out the application form on http://www.cvi.org.uk for bookings. There
are further details of the conference on
http://www.immunise.man.ac.uk/immuniseconference
LATEST PROGRAMME
VACCINES AND IMMUNISATION INTO THE NEXT MILLENNIUM
6-9 SEPTEMBER 1999
UNIVERSITY OF MANCHESTER, UK
SCHOOL OF EPIDEMIOLOGY
Draft1.1 (1st August, 1999)
Monday 6th September 1999
1200 Registration open
CONFERENCE PROGRAMME
DAY 1 (TUESDAY SEPTEMBER 7th)
MORNING
THEME SPECIFIC DISEASE CONTROL
CHAIR
Time Lecture title and speaker
8.00 Poster/ exhibit set up: Coffee and pastries
8.50 Chairperson's welcome and opening remarks
9.0
Keynote presentation
Lessons from smallpox, polio and measles about disease control by
vaccination
Dr. C. de Quadros, Director, Division of Vaccines and Immunization, Pan
American Health Organization. USA
9.40 Respiratory tract infections: Their epidemiology and global
impact
Dr. Lone Simonson, WHO, Geneva
9.55
Influenza disease control: A global control strategy Prof. J
Oxford, Head of
Academic Virology, Department of Medical Virology, St. Bartholomew's
London, UK
10.25
Currently available vaccines and future prospects. Dr. Karl
Nicholson, Senior Lecturer in Infectious Disease, Leicester Royal
Infirmary, UK
10.55 Organisation of influenza vaccination in primary care in a health
district. Dr P Nair
Department of Strategy and Public Health, Bedfordshire Health Authority
[presented paper]
11.05 Interactive question and answer session
Moderator: Dr J Leese, DoH, UK
11.15 Poster/ exhibit viewing and refreshment break
11.35 Pertussis vaccines - the Swedish experience of acellular and whole
cell vaccines.
Dr P Olin , SMI, Sweden
12.05 Interactive question and answer session
Moderators:
Dr W Orenstein Assistant Surgeon General, Director Immunisation (USA)
Dr D Salisbury, Principal Medical Officer, DoH, UK
12.35 LUNCH
12.45-13.15 Workshop 1: Vaccine delivery routes: Mucosal delivery via
the nasal route Professor S Davis, School of Pharmaceutical
Sciences, University of Nottingham, UK
Workshop 2: Vaccine trials update: Live attenuated oral vaccines
against enteric pathogens Dr Myron Levine, Professor and Director Center
for Vaccine Development, University of Maryland, USA
12.35-13.30 Poster and exhibit viewing
CONFERENCE PROGRAMME
DAY 1 (TUESDAY 7TH SEPTEMBER)
AFTERNOON
THEME SPECIFIC DISEASE CONTROL (continued)
CHAIR
Time Lecture title and speaker
13.30 Chairperson's welcome and opening remarks
Meningococcal Disease
13.35 Neisseria meningitidis: Epidemiology of meningococcal Disease
13.45 Conjugate C vaccine trials
Dr. E Miller, PHLS, Communicable Disease Surveillance Centre, London
14.10 Neisseria meningitidis: The development of B vaccines
Professor Keith Cartwright, Director PHLS South West, Gloucester, UK
14.30 Role of the polysaccharide unconjugate vaccine
Prof. Robert Booy, Professor of Child Health, St Bartholomew's
and Royal London Medical & Dental Schools
14.55 Strategies for use of meningococcal vaccines in the USA. Nancy
Rosenstein. Division of Bacterial and Mycotic Diseases. CDC, USA
15.10 Poster/ exhibit viewing and refreshment break
Pneumococcal Disease
15.30
Pneumococcal vaccines - polysaccharide and conjugate vaccines for
children. Professor Juhani Eskola, National Public Health Institute,
Finland
16.00 Pneumococcal vaccines for adults: effectiveness of the
polysaccharide vaccine and the promise of newer vaccines.
Dr. David S. Fedson, Director Medical Affairs, Pasteur-Mérieux MSD,
France
16.30 Interactive question and answer session Moderator: P Paradiso ,
Vice President, Scientific Affairs & Research Strategy, Wyeth Lederle
Vaccines & Paediatrics, NY
16.45 Break and refreshments
Tuberculosis
17.00 BCG vaccine - a review Dr Brigitte Gicquel, The Pasteur
Institute, France
17.30 Progress and Plans for TB Vaccine Development
Dr Ann M. Ginsberg, Program Officer, TB, Leprosy and Other Mycobacterial
Diseases, NIH, USA.
18.00 Vaccine cost efficacy Dr M Miller
18.30 Day 1 Conference closes
18.30 Wyeth Vaccines Satellite Symposium
20.30 Reception - Your chance to meet and talk with today's presenters.
CONFERENCE PROGRAMME
DAY 2 (WEDNESDAY SEPTEMBER 8TH)
MORNING
THEME THE PUBLIC & PROFESSIONAL FACE OF VACCINATION
CHAIR
Time Lecture title and speaker
8.00 Poster/ exhibit set up: Coffee and pastries
8.10 Welcome to breakfast session
8.10 Meet the expert. The development of vaccines against
Cancer. Dr. Peter Stern, Christie Hospital NHS Trust, Manchester.
8.40
8.45 Chairperson's welcome and opening remarks
8.50
Keynote presentation
Active or Passive Immunisation.
Dr. David Salisbury, Department of Health, London.
9.30 Another vaccine scare! Dr Philippe Duclos , Medical Officer in
the department of Vaccines and Other Biologicals at WHO
9.55
Peer review, publishing and publicity.
Dr. Adrian J.Ivinson, Editor, Nature Medicine. NY
10.25
Vaccine issues - a journalist's perspective.
Celia Hall, Medical Editor, Daily Telegraph
10.50 Poster and exhibit viewing and refreshment break
11.15 Parent information needs
Helen Bedford, Senior Research Fellow, Department of Epidemiology and
Public Health, Institute of Child Health and Dr D Elliman, Consultant in
Community Child Health, St. George's Hospital, London.
12.00
Medicine and the Law.
The Law and Litigation concerning vaccination.
Mr. James Badenoch QC, London
12.40 Lunch
12.45-13.15 Workshop 1: Vaccine delivery routes: Transcutaneous
immunization: Potent and practical access to the immune system via the
skin.
Dr Gregory Glenn, Vice President and Scientific Director of Iomai
Corporation , Walter Reed Army Institute of Research, Washington, D.C.
USA
.
Workshop 2: Vaccine trials update: Lyme Vaccine.
Dr Francois Meurice, Director, Clinical Development SmithKline Beecham
Biologicals, Belgium
12.40-13.30 Poster and exhibit viewing
CONFERENCE PROGRAMME
DAY 2 (WEDNESDAY SEPTEMBER 8TH)
AFTERNOON
THEME THE PUBLIC & PROFESSIONAL FACE OF VACCINATION (cont)
CHAIR
Time Lecture title and speaker
13.30 Chairperson's welcome and opening remarks
13.35 Plenary Session: Compulsory universal immunisation - the USA
experience.
Dr. Walter Orenstein, Assistant Surgeon General, Director Immunisation
14.15
Informed consent
Dr Soren Holm, Reader, Centre for Social Ethics, Manchester University
14.40 Poster and exhibit viewing and refreshment break
15.00 SESSION Common childhood infections
Moderator
15.00
Varicella zoster vaccine - its role in disease control.
Dr. Anne Gershon, Columbia Medical Centre, New York, USA.
15.30 Experiences with VZ vaccine in the USA. Dr J Seward. Chief,
Varicella Activity. CDC/National Immunization programme. USA [presented
paper]
15.45
Cost benefit analysis of VZ vaccine in France.
Dr. L. Coudeville, Centre de Recherches Economiques, Sociologiques et de
Gestion, France
16.00 Cost-effectiveness of varicella zoster vaccination in England and
Wales: a preliminary investigation. Dr WJ Edmunds. PHLS, CDSC, UK
[presented paper]
16.10
16.10
Measles vaccine
Professor Heikki Peltola, HYKS, Hospital for Children and Adolescents,
Helsinki, Finland
16.40 Cost effectiveness of vaccination against measles.
Dr. M Miller, WHO, Geneva.
16.55 Break and refreshments
17.15 SESSION Vaccines & Less Industrialised Countries:
Moderator
Opening remarks
17.15
Childhood Immunisation - Challenges For Africa
Dr. Khadija Ali Msambichaka, WHO, Nigeria.
17.45
Immunisation and disease control - lessons from the Caribbean.
Dr P Figueroa. Chief Medical Officer, Jamaica
18.15
Unsafe injections and the transmission of blood borne pathogens in
developing countries. Dr Lone Simonsen, WHO, Geneva.
18.35 The use of sero-epidemiology in developing and monitoring
vaccination programmes - application in less industrialised countries.
Nigel Gay, Immunisation Division, CDSC/PHLS UK
18.45 Day 2 Conference closes
18.45 Satellite symposium - Isosafe
20.45 Conference dinner
CONFERENCE PROGRAMME
DAY 3 (THURSDAY 9TH SEPTEMBER)
MORNING
THEME NEW VACCINE DEVELOPMENTS
CHAIR
Time Lecture title and speaker
7.45 Poster/ exhibit set up: Coffee and pastries
8.00 Welcome to breakfast session
8.00 Licensed meningococcal A/C polysaccharide vaccine in adults induces
immunological hyporesponsiveness. Dr R Borrow, Meningococcal Reference
Unit, Manchester PHLS [presented paper]
8.10 Immunogenicity, reactogencity andpersistence of antibodies of a
meningococcal C conjugate vaccine compared with a meningococcal A and C
polysaccharide vaccine in UK adolescents. Dr J Zuckerman, Academic Unit
of Travel Medicine and Vaccines and Clinical Trials Centre, Royal Free
Hospital, London [presented paper]
8.20 Meningococcal serogroup C conjugate vaccines prime for
immunological memory following a single dose in UK toddlers. Dr P
Richmond, Immunobiology Unit, Institute of Child Health, London
[presented paper]
8.30 Special presentation: Glycoconjugate vaccines
Dr P Paradiso, Vice President, Scientific Affairs & Research Strategy
Wyeth Lederle Vaccines & Paediatrics, NY
8.55 Chairperson's welcome and opening remarks
9.00 Keynote presentation
Organising vaccine trials (including adverse events surveillance) Dr
Myron Levine, Professor and Director Center for Vaccine Development,
University of Maryland, USA
9.40 New approaches to Vaccination.
Professor Paul Henri Lambert, Department of Pathology, University of
Geneva.
10.10
The application of molecular genetics to vaccine development.
Dr. Ian Feavers, Division of Bacteriology, NIBSC. UK
10.35 Poster and exhibit viewing and refreshment break.
10.55
Overview of HIV vaccine development.
Dr. Margaret Johnston, Assistant Director for AIDS Vaccines, NIAID,
Assoc. Director for Vaccine & Prevention Res, DAIDS, NIAID, Bethesda,
Maryland, USA.
11.25
Rotavirus vaccines: Current status and future challenges
Dr Roger I. Glass, Chief, Viral Gastro-enteritis Section Division of
Viral & Rickettsial Diseases, Centers for Disease Control & Prevention,
Atlanta.
11.55 Current Approaches to RSV Vaccine Development.
Dr. Jim Crowe Jnr, Assistant Professor Pediatric Infectious Disease and
Microbiology and Immunology Vanderbilt University, Tennessee, USA.
12.25
Infant Vaccine responses: Limitations and perspectives,
Dr. Claire-Anne Siegrist, WHO collaborating Centre for Neonatal
Vaccinology, University of Geneva
Haemophilus Disease
16.45 Immune responses to Hib vaccine - is the effect of pertussis
vaccine clinically significant? Dr D Goldblatt
12.55 Does needle size matter in infant immunisations? Linda Diggle,
Oxford Vaccine Group [presented paper]
13.05 Lunch
13.15-13.45 Workshop 1: Vaccine delivery routes: Oral delivery
systems.
Professor Vince Lee, University of Southern California
Workshop 2: Vaccine trials update: Meningococcal B
vaccination -the
Cuban experience. Dr Conception Huergo, Cuba
13.05-14.00 Poster and exhibit viewing
CONFERENCE PROGRAMME
DAY 3 (THURSDAY)
AFTERNOON
THEME IMPROVING VACCINE UPTAKE
CHAIR
Time Lecture title and speaker
14.00 Chairperson's welcome and opening remarks
14.05 Keynote presentation Health reform and immunization.
Dr. Bjorn Melgaard, Director Department of Vaccines and other
Biologicals, World Health Organisation, Geneva, Switzerland.
14.45
Vaccine Safety: New Challenges to Vaccine Acceptance
Dr R Chen, Coordinator, Safe Injection Global Network (SIGN) Health
Technology and Pharmaceuticals (HTP) World Health Organization,
Switzerland.
15.15
Workshop
Improving vaccine uptake-an overview.
Dr Joanne Yarwood, Health Education Authority, UK.
Addressing anti-vaccine issues - the parent perspective
Dr B Gellin VUMC, Vanderbilt, USA
Addressing anti-vaccine issues - the professional perspective.
Ann Kemp, South Australia Immunisation Coordinator, CDC Branch,
Australia
17.15 Panel discussion with interactive question and answer session.
Moderator:
17.45 Chair's summation
17.46 Close of Conference
Year 2000 Conference - theme and organisation
Thanks to sponsors
CONFERENCE PROGRAMME
DAY 3 (THURSDAY SEPTEMBER 9TH)
MORNING
THEME PRACTICAL ISSUES - NURSES TRACK
CHAIR
Time Lecture title and speaker
8.00 Poster/ exhibit set up: Coffee and pastries
8.55 Chairperson's welcome and opening remarks
9.00 Keynote presentation
Childhood vaccination into the next millennium
Dr Roy Widdus, Children's Vaccine Initiative, WHO, Geneva.
9.30
Preventing gastro-intestinal tract disease in travellers abroad.
Jeannette Martin, Senior Nurse manager, MRC General practice Research
Framework, London
10.10
Workshop 1
Meningococcal disease control programmes in primary care
Dr E Kaczmarski, PHLS, Manchester
Dr Steve Lockhart, Director, European Clinical Research, Wyeth
LederleVaccines
10.45 Poster and exhibit viewing and refreshment break
11.05 Vaccine cost-efficacy: prevention is really better than cure.
Dr M Miller, WHO , Geneva
11.05 Workshop 2
Pneumococcal disease prevention - the USA experience
Dr Henry Shinefield, and Dr S Black Kaiser Permanente Vaccine Study
Center, California, USA
11.45 Immunising immunocompromised children
Dr. Adam Finn, Division of Child Health, University of Sheffield. UK
12.15 Hepatitis B - new vaccine developments - a solution to
non-responders?
Dr Brian Dickson, Executive Vice President, Clinical Development -
Worldwide, Medeva Pharmaceutical.
12.45 Rapid protection against Hepatitis A and B following accelerated
schedule of Twinrix
Dr J Zuckerman, Academic Unit of Travel Medicine and Vaccines and
Clinical Trials Centre, Royal Free Hospital, London [presented paper]
12.55 A clinical study to assess the safety and immunogenicity of Rhesus
Diploid Cell Rabies Vaccine. Dr S Bhardwaj. Serum Institute of India
[presented paper]
13.05 Lunch
1.15-1.50 Workshop 3
Epidemiology of diarrhoeal infections in community child care
nurseries. JP Buttery [presented paper]
Control of diarrhoeal infections in community child care nurseries. Dr
Mary Ramsay, CDCS, UK
13.00-14.00 Poster and exhibit viewing
14.00 Do I need a protocol? Ms Karen Howell, Risk Management
Consultant, Director of Travel Health Ltd, Staffordshire.
14.30 How to run a travel clinic,. Dr Hugh Porter, GP Nottingham
15.00 Preparing the sportsman for travel. Dr. Mike Stone, Manchester
United FC
15.30 Poster and exhibit viewing and refreshment break
15.45 Workshop 4
Recognition and management of anaphylaxis. Dr Anthony F T Brown, Assoc.
Prof., Department of Emergency Medicine, Royal Brisbane Hospital,
Australia.
16.45 Conference closes
1st Global Conference on Vaccines and Immunisation into the next
millennium
6-9 September 1999, Manchester, UK
REGISTRATION FORM
Registration may be made up to and including 15 August 1999. After this
date delegates can register on-site. Please return form to: CCS, 19
King Edward Street, Macclesfield, Cheshire, SK10 !AQ
Fax: +44 (0)1625 624075 e-mail: [log in to unmask] Tel: +44 (0)1625 624091
Title: (Prof., Dr, Mr, Mrs, Miss, Ms)
First Name
Family Name
Position
Organisation
Address
Tel No.
Fax No.:
E-mail:
Address for correspondence (if different from above)
Registration Fee (please indicate)
Delegate
Up to 15 August £300
After 15 August £350
Accompanying Person
Up to 15 August £90
After 15 August £90
Nurses
Up to 15 August £175
After 15 August £200
Day rate £50
Students
Up to 15 August £100
After 15 August £100
Day rate £25
Names (s) of Accompanying Person (s)
*please note that the reduced fee applies only if both the registration
form and payment are received by the due date.
The Accompanying Person's registration fee entitles guests to coffee,
lunch and the Welcome Reception, but does not allow access to any
sessions.
Hotel Registration Form (A deposit of UK£100 per room is required)
Please indicate your requirements in the appropriate box.
Group
Total number of single rooms
Total number of double rooms
Arrival
Date Departure Date
Total Deposit paid (UK£)
Up to UK£50 per night
UK£50 to UK£75 per night
Over UK£75 per night
METHOD OF PAYMENT
Costs
Total Registration (UK£) ________________________________________
Total Hotel Deposit (UK£) ________________________________________
TOTAL (UK£) ________________________________________
Cheque
UK delegates may send personal cheques made payable to Global Conference
on Vaccines and Immunisation. No other personal cheques will be
accepted.
Bank Draft
Bank drafts, drawn on a UK bank, should be made payable to Global
Conference on Vaccines and Immunisation.
Bank-to-bank transfer
Bank transfers should be made to the following bank account: National
Westminster Bank, 2, Chestergate, Macclesfield, Cheshire, SK11 6BS, UK.
Bank sort code: 01-05-41. Account number: 53513932. Please make your
bank transfer payable to Global Conference on Vaccines and Immunisation.
Credit card
Payment by Visa, Mastercard or American Express. If you wish to pay by
credit card, please complete the following:
Credit card type (e.g. Visa, Mastercard, etc.)
____________________________
Credit card number
Expiry date: ____________________________________________________
Name of cardholder ______________________________________________
Billing address ______________________________________________
______________________________________________
Amount to be debited UK£___________________________________________
Signature_________________________________________________________
N.B. All registrations and hotel booking forms must be accompanied by
appropriate payment. Registration forms without payment will not be
accepted.
__________________________________________________________
Andrea Lofthouse
Pumpkin Web Page Design, Desk Top Publishing & Multimedia Presentations
Tel: +44 (0) 161 610 1260
Mobile: 0958 351156
http://www.clal.co.uk/Pumpkin
http://www.clal.co.uk/DTP
('v')
(( ))
-"---"-
__________________________________________________________
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|
